Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Antigen Exposure History Defines CD8 T Cell Dynamics and Protection during Localized Pulmonary Infections.

Van Braeckel-Budimir N, Martin MD, Hartwig SM, Legge KL, Badovinac VP, Harty JT.

Front Immunol. 2017 Jan 27;8:40. doi: 10.3389/fimmu.2017.00040. eCollection 2017.

2.

Influenza and Memory T Cells: How to Awake the Force.

Spitaels J, Roose K, Saelens X.

Vaccines (Basel). 2016 Oct 13;4(4). pii: E33. Review.

3.

High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.

Kim JH, Talbot HK, Mishina M, Zhu Y, Chen J, Cao W, Reber AJ, Griffin MR, Shay DK, Spencer SM, Sambhara S.

Vaccine. 2016 Aug 31;34(38):4594-601. doi: 10.1016/j.vaccine.2016.07.018. Epub 2016 Jul 26.

PMID:
27473306
4.

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.

Schotsaert M, Ysenbaert T, Smet A, Schepens B, Vanderschaeghe D, Stegalkina S, Vogel TU, Callewaert N, Fiers W, Saelens X.

Sci Rep. 2016 Apr 13;6:24402. doi: 10.1038/srep24402.

5.

A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.

Caspard H, Heikkinen T, Belshe RB, Ambrose CS.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1721-7. doi: 10.1080/21645515.2015.1115164.

6.

Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.

Kim JH, Liepkalns J, Reber AJ, Lu X, Music N, Jacob J, Sambhara S.

Vaccine. 2016 Jan 20;34(4):495-502. doi: 10.1016/j.vaccine.2015.11.077. Epub 2015 Dec 17.

7.

M2e-Based Universal Influenza A Vaccines.

Deng L, Cho KJ, Fiers W, Saelens X.

Vaccines (Basel). 2015 Feb 13;3(1):105-36. doi: 10.3390/vaccines3010105. Review.

8.

Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.

Vesikari T, Forstén A, Arora A, Tsai T, Clemens R.

Hum Vaccin Immunother. 2015;11(8):2102-12. doi: 10.1080/21645515.2015.1044167.

9.

Human Influenza A Virus-Specific CD8+ T-Cell Response Is Long-lived.

van de Sandt CE, Hillaire ML, Geelhoed-Mieras MM, Osterhaus AD, Fouchier RA, Rimmelzwaan GF.

J Infect Dis. 2015 Jul 1;212(1):81-5. doi: 10.1093/infdis/jiv018. Epub 2015 Jan 12.

10.

Influenza vaccines: a moving interdisciplinary field.

Schotsaert M, García-Sastre A.

Viruses. 2014 Oct 9;6(10):3809-26. doi: 10.3390/v6103809. Review.

11.

Universal immunity to influenza must outwit immune evasion.

Quiñones-Parra S, Loh L, Brown LE, Kedzierska K, Valkenburg SA.

Front Microbiol. 2014 Jun 12;5:285. doi: 10.3389/fmicb.2014.00285. eCollection 2014. Review.

12.

T cell responses to viral infections - opportunities for Peptide vaccination.

Rosendahl Huber S, van Beek J, de Jonge J, Luytjes W, van Baarle D.

Front Immunol. 2014 Apr 16;5:171. doi: 10.3389/fimmu.2014.00171. eCollection 2014. Review.

13.

Influenza vaccination in children at high risk of respiratory disease.

Patria MF, Tagliabue C, Longhi B, Esposito S.

Ther Adv Vaccines. 2013 May;1(1):21-31. doi: 10.1177/2051013613480770.

14.

Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.

Dolfi DV, Mansfield KD, Kurupati RK, Kannan S, Doyle SA, Ertl HC, Schmader KE, Wherry EJ.

PLoS One. 2013 Oct 14;8(10):e77164. doi: 10.1371/journal.pone.0077164. eCollection 2013.

15.

Cutting edge: rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the Flumist vaccine.

Slütter B, Pewe LL, Lauer P, Harty JT.

J Immunol. 2013 Apr 15;190(8):3854-8. doi: 10.4049/jimmunol.1202790. Epub 2013 Mar 6.

16.

Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.

Huijskens EG, Reimerink J, Mulder PG, van Beek J, Meijer A, de Bruin E, Friesema I, de Jong MD, Rimmelzwaan GF, Peeters MF, Rossen JW, Koopmans M.

PLoS One. 2013;8(1):e54890. doi: 10.1371/journal.pone.0054890. Epub 2013 Jan 24.

17.

Cross-protective immune responses elicited by live attenuated influenza vaccines.

Jang YH, Seong BL.

Yonsei Med J. 2013 Mar 1;54(2):271-82. doi: 10.3349/ymj.2013.54.2.271. Review.

18.

Evasion of influenza A viruses from innate and adaptive immune responses.

van de Sandt CE, Kreijtz JH, Rimmelzwaan GF.

Viruses. 2012 Sep;4(9):1438-76. doi: 10.3390/v4091438. Epub 2012 Sep 3. Review.

19.

Novel viral vectored vaccines for the prevention of influenza.

Lambe T.

Mol Med. 2012 Oct 24;18:1153-60. doi: 10.2119/molmed.2012.00147. Review.

20.

Characterization of the human CD8⁺ T cell response following infection with 2009 pandemic influenza H1N1 virus.

Hillaire ML, van Trierum SE, Bodewes R, van Baalen CA, van Binnendijk RS, Koopmans MP, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2011 Nov;85(22):12057-61. doi: 10.1128/JVI.05204-11. Epub 2011 Sep 14.

Supplemental Content

Support Center